The present invention provides tumor-targeting peptides. The peptides can be used in detecting tumor cells when binding with a reporting agent. The peptides can also be used in treating cancers when binding with an anti-cancer drug. A further purpose of the present invention is to provide a pharmaceutical composition for treating cancers and a kit and method for detecting tumor cells.